Evidence map›Paper›PMID 30567531›Full record

ArticleBMC cancer2018

Genomic alterations in gastric cancers discovered via whole-exome sequencing.

Jie Zhang, Weiqing Qiu, Hua Liu, Changlin Qian, Dujuan Liu, Hailong Wang, Ni Hu, Y Tom Tang, Jianhua Sun, Zhiyong Shen

Abstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jie ZhangDepartment of General Surgery, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 2000 Jiangyue Road, Shanghai, 201112, China.
Weiqing QiuDepartment of General Surgery, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 2000 Jiangyue Road, Shanghai, 201112, China.
Hua LiuDepartment of General Surgery, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 2000 Jiangyue Road, Shanghai, 201112, China.
Changlin QianDepartment of General Surgery, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 2000 Jiangyue Road, Shanghai, 201112, China.
Dujuan LiuFirst Dimension Biosciences (SuZhou) Co., Ltd, Building B8, Floor 5, BioBay, 218 Xinghu Street, Industrial Park District, Suzhou, 215126, Jiangsu, China.
Hailong WangFirst Dimension Biosciences (SuZhou) Co., Ltd, Building B8, Floor 5, BioBay, 218 Xinghu Street, Industrial Park District, Suzhou, 215126, Jiangsu, China.
Ni HuFirst Dimension Biosciences (SuZhou) Co., Ltd, Building B8, Floor 5, BioBay, 218 Xinghu Street, Industrial Park District, Suzhou, 215126, Jiangsu, China.
Y Tom TangFirst Dimension Biosciences (SuZhou) Co., Ltd, Building B8, Floor 5, BioBay, 218 Xinghu Street, Industrial Park District, Suzhou, 215126, Jiangsu, China.
Jianhua SunDepartment of General Surgery, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 2000 Jiangyue Road, Shanghai, 201112, China. sunjianhua5566@hotmail.com.
Zhiyong ShenDepartment of General Surgery, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 2000 Jiangyue Road, Shanghai, 201112, China. szydoc@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric cancer (GC) ranks the second in mortality rate among all cancers. Metastases account for most of the deaths in GC patients. Yet our understanding of GC and its metastasis mechanism is still very limited.

methodsWe performed 20 whole-exome sequencing (WES) on 5 typical metastatic gastric adenocarcinoma (GAC) patients with lymph node metastasis. We compared both the primary tumors to their metastatic lymph nodes, and a specific analysis pipeline was used to detect single nucleotide variants (SNVs), small insertions/deletions (indels) and copy number variants (CNVs).

results(1) We confirmed 30 candidate mutations in both primary and lymph nodes tissues, and other 7 only in primary tumors. (2) Copy number gains were observed in a large section of 17q12-21, as well as copy number losses in regions containing CDKN2A and CDKN2B in both primary and lymph nodes tissues.

conclusionsOur results provide preliminary insights in the molecular mechanisms of GC initiation, development, and metastatic progression. These results need to be validated through large-scale studies.

Indexed as

Exome SequencingAdenocarcinomaCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p16DNA Copy Number VariationsExomeGenome, HumanGenomic InstabilityGenomicsHumansINDEL MutationLymph NodesMaleStomach NeoplasmsCDKN2A protein, humanCDKN2B protein, humanCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p16Candidate mutationsCopy number variation (CNV)Gastric adenocarcinoma (GAC)MetastasisSNPWhole-exome sequencing

Identifiers

PMID30567531
PMCPMC6299976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.